Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0000 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/10/15 All times are local (Market data is delayed by at least 15 minutes).

premd inc (PREMF) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/17/14 - $0.0001
52 Week Low
10/17/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PREMD INC (PREMF)

Related News

No related news articles were found.

premd inc (PREMF) Related Businessweek News

No Related Businessweek News Found

premd inc (PREMF) Details

PreMD, Inc., a predictive medicine company, develops non-invasive tests for the early detection of cardiovascular disease and cancer. It is developing tests designed for use at the point of care, in the doctor’s office, at the pharmacy, and at home. The company’s coronary artery disease risk assessment technology products include PREVU* Point of Care Skin Cholesterol Test that provides information about an individual’s risk of coronary artery disease, which obtained FDA clearance for commercial sale; PREVU* LT Skin Cholesterol Test, a lab-processed skin cholesterol test; and PREVU* PT Skin Cholesterol Test, a semi-quantitative consumer test that is under prototype development for home use. Its cancer tests under development include ColorectAlert and Coolpath mucus tests for the detection of colorectal cancer; LungAlert, a sputum test for the detection of lung cancer; and a nipple aspirate test for the detection of breast cancer. It has a license agreement with AstraZeneca Pharmaceuticals LP to market and distribute its skin cholesterol test in the United States. The company, formerly known as IMI International Medical Innovations, Inc., was founded in 1992 and is headquartered in Toronto, Canada.

premd inc (PREMF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PREMF:US $0.00 USD 0.00

PREMF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PREMF.
View Industry Companies

Industry Analysis


Industry Average

Valuation PREMF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PREMD INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at